SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT

QR Code

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT

A high prevalence of thrombotic disorders, insufficient effectiveness or safety of antithrombotic therapy is an urgent problem of modern healthcare. The main means of preventing thrombosis is acetylsalicylic acid. Despite its long history, aspirin attracts researchers in the fields of medicinal chem...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. K. Brel, N. V. Atapina, Yu. N. Budaeva, S. V. Lisina, S. S. Tsaruk, D. V. Kurkin, I. N. Tyurenkov
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2021-08-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	antiplatelet agents antiplatelet activity antithrombotic activity acetylsalicylic acid platelet aggregation taurine
Online Access:	https://www.pharmpharm.ru/jour/article/view/863
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

Current Guidelines on Antithrombotic Management in Patients Undergoing Gastrointestinal Endoscopy
by: Muhammad Begawan Bestari, et al.
Published: (2019-05-01)

Current Guidelines on Antithrombotic Management in Patients Undergoing Gastrointestinal Endoscopy
by: Muhammad Begawan Bestari, et al.
Published: (2019-05-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

Effect of benzoyl taurine dipotassium salt on coagulation, hemostasis and vascular activity in the microvasculature of the brain in violation of cerebral circulation
by: V. E. Pustynnikov, et al.
Published: (2022-10-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice
by: N. F. Puchinyan, et al.
Published: (2016-09-01)

Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period
by: T. P. Pronko, et al.
Published: (2025-01-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study
by: N. V. Lomakin, et al.
Published: (2020-07-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

The resolution of the Expert Council on current issues of the use of acetylsalicylic acid for the purpose of primary prevention of cardiovascular diseases in the light of new scientific data and updated clinical guidelines
by: O. M. Drapkina, et al.
Published: (2023-01-01)

Modern Approaches to Optimal Antithrombotic Therapy for Stable Ischemic Heart Disease
by: G. E. Roytberg, et al.
Published: (2020-10-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

ANTIPLATELET TREATMENT IN ST ELEVATION ACUTE CORONARY SYNDROME UNDER REAL CLINICAL CIRCUMSTANCES: THE DYNAMICS OF THROMBOCYTE FUNCTION
by: L. I. Malinova, et al.
Published: (2017-02-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion
by: A. L. Komarov, et al.
Published: (2018-05-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms
by: O. N. Dzhioeva, et al.
Published: (2023-01-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

The study of price situation on the domestic antiplatelet market
by: Ye. А. Redkina, et al.
Published: (2017-08-01)

EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE
by: V. N. Drozdov, et al.
Published: (2016-01-01)

Comparative effectiveness of antiplatelet therapy of hemostatic disorders in diabetes of the second type
by: S. A. Pavlishcuk, et al.
Published: (2015-08-01)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Platelet phenotypes and practical aspects of platelet function testing in cardiology
by: Zh. D. Kobalava, et al.
Published: (2023-12-01)

NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01)

Tirofiban Combination Therapy for Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
by: Abdullah Bin Kamran, et al.
Published: (2025-06-01)

PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
by: A. L. Komarov, et al.
Published: (2015-03-01)

ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS
by: L. I. Buriachkovskaia, et al.
Published: (2016-01-01)

ANTITROMBOTIC ACTIVITY OF A NEW BENZIMIDAZOLE DERIVATIVE WITH A SPATIALLY DIFFICULT PHENOLIC SUBSTITUTE IN ITS STRUCTURE
by: Alexander A. Spasov, et al.
Published: (2020-10-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

POTENTIAL APPLICATION OF HAWTHORN IN NEUROLOGY
by: S.R. KHASANOVA, et al.
Published: (2025-07-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

PRAVASTATIN IN CORRECTION OF VESSEL WALL ANTIPLATELET CONTROL OVER THE BLOOD CELLS IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2014-12-01)

ANTIPLATELET THERAPY IN THE PREVENTION OF CEREBROVASCULAR ACCIDENTS
by: O. V. Rodionova, et al.
Published: (2017-03-01)

Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion
by: D. V. Pevsner, et al.
Published: (2022-09-01)

Dynamics of hemostasis system parameters in assessing the risk of complications in the patients with acute myocardial infarction receiving antiplatelet therapy
by: T. R. Gvindzhiliya, et al.
Published: (2024-09-01)

Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
by: Ma Shi-jie, et al.
Published: (2025-07-01)

Antiplatelet Resumption After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis
by: Sarah Yahya Alharthi, et al.
Published: (2025-07-01)